DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,583,823 | +4.6% | 203,884 | +1.2% | 0.66% | +7.9% |
Q2 2023 | $48,350,185 | +106.8% | 201,460 | +117.2% | 0.61% | +93.9% |
Q1 2023 | $23,379,183 | -0.6% | 92,760 | +4.6% | 0.31% | -4.6% |
Q4 2022 | $23,529,554 | +5.3% | 88,650 | +2.5% | 0.33% | -8.1% |
Q3 2022 | $22,346,000 | +1.9% | 86,515 | +0.0% | 0.36% | +6.6% |
Q2 2022 | $21,927,000 | -10.4% | 86,492 | +3.6% | 0.34% | -1.5% |
Q1 2022 | $24,480,000 | -4.8% | 83,454 | +6.8% | 0.34% | -6.1% |
Q4 2021 | $25,711,000 | +10.4% | 78,147 | +2.1% | 0.36% | -1.6% |
Q3 2021 | $23,292,000 | +15.7% | 76,508 | +2.0% | 0.37% | +12.9% |
Q2 2021 | $20,134,000 | +23.7% | 75,023 | +3.7% | 0.33% | +12.4% |
Q1 2021 | $16,282,000 | -3.2% | 72,339 | -4.5% | 0.29% | -6.5% |
Q4 2020 | $16,820,000 | +2.1% | 75,716 | -1.0% | 0.31% | -7.2% |
Q3 2020 | $16,467,000 | +29.8% | 76,475 | +6.6% | 0.33% | +19.7% |
Q2 2020 | $12,690,000 | +24.9% | 71,766 | -2.2% | 0.28% | +12.0% |
Q1 2020 | $10,158,000 | -12.8% | 73,393 | -3.3% | 0.25% | +14.2% |
Q4 2019 | $11,653,000 | +5.6% | 75,928 | -0.6% | 0.22% | -1.4% |
Q3 2019 | $11,037,000 | +4.2% | 76,419 | +3.1% | 0.22% | +1.8% |
Q2 2019 | $10,595,000 | +8.0% | 74,130 | -0.3% | 0.22% | +3.3% |
Q1 2019 | $9,813,000 | +27.4% | 74,333 | -0.5% | 0.21% | +12.9% |
Q4 2018 | $7,704,000 | -6.3% | 74,713 | -1.2% | 0.19% | +8.1% |
Q3 2018 | $8,220,000 | +12.1% | 75,644 | +1.8% | 0.17% | +7.5% |
Q2 2018 | $7,331,000 | +81.8% | 74,288 | +80.3% | 0.16% | +77.8% |
Q1 2018 | $4,033,000 | +5.5% | 41,194 | +0.0% | 0.09% | +8.4% |
Q4 2017 | $3,823,000 | +6.2% | 41,185 | -1.9% | 0.08% | -1.2% |
Q3 2017 | $3,601,000 | -53.3% | 41,984 | -54.0% | 0.08% | -56.0% |
Q2 2017 | $7,704,000 | -0.6% | 91,293 | +0.8% | 0.19% | -3.0% |
Q1 2017 | $7,747,000 | +30.4% | 90,574 | +18.6% | 0.20% | +15.2% |
Q4 2016 | $5,943,000 | +51.2% | 76,345 | +52.3% | 0.17% | +54.1% |
Q3 2016 | $3,931,000 | -21.2% | 50,142 | +1.5% | 0.11% | -27.0% |
Q2 2016 | $4,988,000 | +5.5% | 49,387 | -1.0% | 0.15% | +1.3% |
Q1 2016 | $4,730,000 | +2100.0% | 49,867 | +2058.7% | 0.15% | +2042.9% |
Q4 2015 | $215,000 | – | 2,310 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |